Corteva, Inc. logo CTVA - Corteva, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 25
HOLD 10
SELL 2
STRONG
SELL
0
| PRICE TARGET: $38.64 DETAILS
HIGH: $101.00
LOW: $15.00
MEDIAN: $17.00
CONSENSUS: $38.64
UPSIDE: 223.35%

Stock News

Corteva: A 'Buy' On Constructive Growth And Margin Outlook

Corteva: A 'Buy' On Constructive Growth And Margin Outlook

Corteva, Inc. is rated 'Buy', underpinned by robust growth and profitability levers. CTVA targets +3% annualized top-line expansion (FY26–29), outpacing the global crop protection sector, aided by past and future portfolio enhancements. CTVA is expected to deliver a cumulative 150bps EBITDA margin expansion and +6% EBITDA CAGR over the FY2026-FY2029 period, driven by cost reductions and a shift toward higher-margin biologicals.

Oct 09, 2026 12:29 AM • seekingalpha.com
Corteva Begins New Chapter as Focused, Innovation-Led, Global Crop Protection Leader

Corteva Begins New Chapter as Focused, Innovation-Led, Global Crop Protection Leader

Company completes spin-off of seed business, well positioned to advance its robust pipeline with 12 new actives, including 5 biologicals, for launch in the next decade INDIANAPOLIS, Oct. 1, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it has successfully spun off its advanced seed and genetics business and will move forward as a leading, pure-play global crop protection company. "This is a new day for Corteva, and we couldn't be more excited as we move forward with greater focus, agility and a renewed commitment to innovation and operational excellence," said Corteva CEO Luke Kissam.

Oct 01, 2026 04:00 AM • prnewswire.com

Price Targets